Breaking News, Collaborations & Alliances

CEPI Inks COVID-19 Vax Pact with Clover Bio

Becomes ninth global COVID-19 vaccine development project that CEPI has signed since Jan 23, 2020

By: Contract Pharma

Contract Pharma Staff

CEPI, the Coalition for Epidemic Preparedness Innovations, has signed a ninth worldwide collaboration to develop a COVID-19 vaccine. CEPI will invest an initial $3.5 million in a partnering agreement with Clover Biopharmaceuticals Australia, the wholly-owned subsidiary of Sichuan Clover Biopharmaceuticals, Inc. (China). The deal brings the organization’s total investment in COVID-19 vaccine research and development to $39.6 million.   This initial CEPI investment will support Clover Australia in...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters